July 26, 2016 2:18 PM ET

Pharmaceuticals

Company Overview of Progen Pharmaceuticals, Inc.

Key Executives for Progen Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Thomas D. Kiley Esq.14 RelationshipsCo-Founder and Director73

Progen Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas D. Kiley Esq. 14 RelationshipsProgen Pharmaceuticals, Inc.73
Michael G. Raab 28 RelationshipsArdelyx, Inc.51
Anthony E. Pegg Ph.D. 6 RelationshipsProgen Pharmaceuticals, Inc.--
Randall K. Johnson Ph.D. 77 RelationshipsTetraLogic Pharmaceuticals Corporation69
Daniel Douglas Von Hoff M.D., F.A.C.P. 549 RelationshipsOncolytics Biotech Inc.68
View All Board Members

Progen Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
434.4K
Bonus
531.9K
Total Short Term Compensation
641.7K
Total Value of Options
20.5M
Compensation as of Fiscal Year
Progen Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bristol-Myers Squibb Company Announces Executive Changes
July 25, 2016 3:00 PM ET
Nutritional High International Inc. Announces Management Changes
July 25, 2016 1:06 PM ET
Petlife Pharmaceuticals, Inc. Announces Management Appointments
July 25, 2016 12:00 PM ET
Lannett Company, Inc. Announces Executive Promotions
July 25, 2016 10:54 AM ET
Mallinckrodt plc Announces Resignation of Nancy S. Lurker from its Board
July 22, 2016 8:36 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Progen Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.